+ Watch ILMN
on My Watchlist
The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.
Next generation sequencing is changing the field of Genetics. Look for the technology to move from the research market to the clinical market in the next 2-5 years. This will led to 20%+ growth of the market for many years. Illumina is the clear leader in the field, good margins, good earnings growth.
How in the world did you get a start price of 32.62 on 2/1/2011?
Oh, yeah, LOL. I picked this a while back, but just now wrote my pitch. Thought maybe I'd start doing pitches now that they're giving out charms for them:)
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions